Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NorthWest Healthcare Properties Real Estate Invest 10 Convert Sub Debentures 31 March 2025 T.NWH.DB.G

Alternate Symbol(s):  T.NWH.DB.H | T.NWH.DB.I | T.NWH.UN | NWHUF

NorthWest Healthcare Properties Real Estate Investment Trust is a Canada-based open-ended real estate investment trust. The Company operates in the healthcare real estate industry segment. Its businesses include funds management, asset management, and development. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings; life sciences, research, and education. It provides a portfolio of international healthcare real estate infrastructure comprised of interests in a diversified portfolio of about 233 properties and 18.6 million square feet of gross leasable area located throughout markets in Canada, Brazil, Europe, Australia and New Zealand. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies.


TSX:NWH.DB.G - Post by User

Post by Possibleidiot01on Sep 25, 2023 7:38pm
241 Views
Post# 35653571

Trevor Rose's Insights - DON'T BUY

Trevor Rose's Insights - DON'T BUY
DON'T BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research The distribution cut was needed, but of course was fairly large (55%). The asset sales are a good start but challenges remain. The strategic review is only seven weeks old, but reading between the lines it sounds like there has not been huge interest yet. It is hard to endorse this right now. With higher rates and lower assets (from sales), growth will be hard to come by. We might be reluctant to sell it on the first trading day of this news, but we certainly think it can be 'targetted' for elimination from an investor's portfolio and used as a source of cash for other ideas. The stock will likely be in the penalty box for some time for multiple disappointments over the past year, with a business that is supposed to be more reliable and more predictable. We would not see solvency as an issue but it is just hard to like right now.


<< Previous
Bullboard Posts
Next >>